Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

The Lancet Infectious Diseases

Topics

Medicine

Epidemiology

Immunology

Internal Medicine

Gastroenterology

Show all topics

DOI

10.1016/s1473-3099(16)00052-9

Other Formats

PDF